{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:05:22Z","timestamp":1777899922500,"version":"3.51.4"},"reference-count":14,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T00:00:00Z","timestamp":1506643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Scott Med J"],"published-print":{"date-parts":[[2017,11]]},"abstract":"<jats:p>Multiple myeloma is a haematological disease caused by proliferation of malignant plasma cells in bone marrow. It frequently has lytic bone lesions. However, involvement of the small bones of the hands and feet is extremely rare. We report a unique multiple myeloma patient with first recurrence in navicular bone after allogenic stem cell transplantation.<\/jats:p>","DOI":"10.1177\/0036933017727962","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T07:54:30Z","timestamp":1506671670000},"page":"152-155","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["A case of multiple myeloma with navicular bone involvement"],"prefix":"10.1177","volume":"62","author":[{"given":"Esra","family":"Yildizhan","sequence":"first","affiliation":[{"name":"MD, Hematologist, Erciyes University School of Medicine, Hematology Department, M. Kemal Dedeman Oncology Hospital, Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leylagul","family":"Kaynar","sequence":"additional","affiliation":[{"name":"2 MD, Assoc. prof, Erciyes University School of Medicine, Hematology Department, M. Kemal Dedeman Oncology Hospital, Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolette","family":"Tiren","sequence":"additional","affiliation":[{"name":"MD, Hematologist, Erciyes University School of Medicine, Hematology Department, M. Kemal Dedeman Oncology Hospital, Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozlem","family":"canoz","sequence":"additional","affiliation":[{"name":"MD, Prof., Erciyes University School of Medicine, Pathology Department, Gevher Nesibe Hospital Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bulent","family":"Eser","sequence":"additional","affiliation":[{"name":"MD, Prof., Erciyes University School of Medicine, Hematology Department, M. Kemal Dedeman Oncology Hospital, Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2017,9,29]]},"reference":[{"key":"bibr1-0036933017727962","unstructured":"Dispenzieri A, Lacy MQ and Kumar S. Multiple myeloma. In: Greer JP, Arber DA, Glader B, List AF, Means RT, Paraskevas F, Rodgers GM (eds)\n                      Wintrobe\u2019s clinical hematology\n                      . 13th ed. Philadelphia, PA: Lippincott Williams and Wilkins, 2014, pp.2046\u20132097."},{"key":"bibr2-0036933017727962","unstructured":"Cancer research UK, http:\/\/www.cancerresearchuk.org\/about-cancer\/type\/myeloma\/treatment\/statistics-and-outlook-for-myeloma (2016, accessed 5 April 2016)."},{"key":"bibr3-0036933017727962","unstructured":"National cancer institute surveillance, epidemiology, and end results program, http:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html (2016, accessed 5 April 2016)."},{"key":"bibr4-0036933017727962","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldu016"},{"key":"bibr5-0036933017727962","doi-asserted-by":"publisher","DOI":"10.4137\/CGM.S16817"},{"key":"bibr6-0036933017727962","doi-asserted-by":"publisher","DOI":"10.7547\/87507315-87-5-233"},{"key":"bibr7-0036933017727962","doi-asserted-by":"publisher","DOI":"10.1177\/107110078800800611"},{"key":"bibr8-0036933017727962","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609093451"},{"key":"bibr9-0036933017727962","doi-asserted-by":"publisher","DOI":"10.7547\/87507315-78-12-636"},{"key":"bibr10-0036933017727962","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20442"},{"key":"bibr11-0036933017727962","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910701)68:1<202::AID-CNCR2820680137>3.0.CO;2-U"},{"key":"bibr12-0036933017727962","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950050128"},{"key":"bibr13-0036933017727962","first-page":"511","volume":"84","author":"Scutellari PN","year":"1993","journal-title":"Minerva Med"},{"key":"bibr14-0036933017727962","doi-asserted-by":"publisher","DOI":"10.5312\/wjo.v5.i3.272"}],"container-title":["Scottish Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0036933017727962","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0036933017727962","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0036933017727962","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:18:21Z","timestamp":1777630701000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0036933017727962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,29]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.1177\/0036933017727962"],"URL":"https:\/\/doi.org\/10.1177\/0036933017727962","relation":{},"ISSN":["0036-9330","2045-6441"],"issn-type":[{"value":"0036-9330","type":"print"},{"value":"2045-6441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,29]]}}}